We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This document brings together all the guidelines that relate to the NHS newborn and infant physical examination (NIPE) screening programme.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
Safety leaflet to help you understand the latest information about the effects of pregabalin during pregnancy.
Guidance on clinical trials that are categorised as ‘notifiable’.
How to use a combination of quantitative and qualitative data to evaluate your digital health product.
This overview is aimed at professionals working in the NHS newborn blood spot (NBS) screening programme.
Patient group direction (PGD) template to support the national diphtheria, tetanus and inactivated poliomyelitis (Td/IPV – Revaxis®) vaccination programme.
Infographic explaining the physical activity needed for general health benefits for children under 5 years of age.
Contact information for general enquiries on health and care.
Information for students and higher education institutions about the NHS Bursary Scheme rules that apply for the academic year 2025 to 2026.
Post-exposure prophylaxis (PEP) is offered to individuals at high risk of severe chickenpox following an exposure.
Helping public health practitioners conducting evaluations – what the evaluation is, when it should be undertaken and the different types of evaluation available.
Documents to help local authorities and providers commission and deliver maternal and child public health services from preconception up to 24 years.
Take care when using creams to treat dry skin conditions as they can easily dry onto clothing, bedding and bandages making them more flammable.
This guidance identifies common issues with validation and assessment of clinical trial applications and how to avoid them.
A wholesale dealer in Great Britain may import Qualified Person certified medicines from the European Economic Area if certain checks are made by the ‘Responsible Person (import)’
The process for applicants applying for a paediatric investigation plan (PIP) modification or waiver.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Infographic explaining the physical activity needed for general health benefits for children and young people aged 5 to 18 years.
You must include the appropriate legal basis for your application when you apply to MHRA for a marketing authorisation.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).